GOLDMAN SACHS GROUP INC - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 45 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$251,672
-47.8%
558,650
-39.0%
0.00%
Q3 2022$482,000
-19.7%
915,695
-22.9%
0.00%
Q2 2022$600,000
-76.8%
1,187,293
+5.6%
0.00%
-100.0%
Q1 2022$2,587,000
-52.0%
1,124,789
-0.8%
0.00%0.0%
Q4 2021$5,388,000
-40.3%
1,134,351
-0.1%
0.00%
-50.0%
Q3 2021$9,031,000
+14.7%
1,136,050
+0.4%
0.00%0.0%
Q2 2021$7,873,000
-12.5%
1,131,059
-0.5%
0.00%0.0%
Q1 2021$9,002,000
+163.1%
1,136,673
+161.5%
0.00%
+100.0%
Q4 2020$3,421,000
+7.8%
434,725
-2.9%
0.00%0.0%
Q3 2020$3,174,000
-24.5%
447,727
-1.5%
0.00%0.0%
Q2 2020$4,206,000
+114.0%
454,734
+7.9%
0.00%0.0%
Q1 2020$1,965,000
-41.8%
421,565
-4.6%
0.00%0.0%
Q4 2019$3,377,000
+1.0%
442,050
+1.6%
0.00%0.0%
Q3 2019$3,345,000
+23.3%
434,999
+9.8%
0.00%0.0%
Q2 2019$2,713,000
-16.5%
396,082
-1.8%
0.00%0.0%
Q1 2019$3,248,000
+2360.6%
403,424
+2182.7%
0.00%
Q4 2018$132,000
-27.9%
17,673
-7.7%
0.00%
Q3 2018$183,000
+1.1%
19,155
+11.7%
0.00%
Q2 2018$181,000
+53.4%
17,143
+44.1%
0.00%
Q1 2018$118,000
+162.2%
11,900
+14.6%
0.00%
Q4 2016$45,000
-78.8%
10,386
-68.6%
0.00%
Q3 2016$212,000
-22.3%
33,026
-41.3%
0.00%
Q2 2016$273,00056,2340.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 524,929$2,588,0006.20%
DAFNA Capital Management LLC 349,592$1,723,0001.07%
Nantahala Capital Management 1,602,903$7,902,0000.39%
Sio Capital Management, LLC 129,583$639,0000.33%
Rock Springs Capital Management LP 524,089$2,584,0000.12%
Orbimed Advisors 1,469,524$7,244,0000.07%
Baker Brothers Advisors 1,137,872$5,609,0000.04%
Lee Financial Co 22,408$110,0000.04%
Spark Investment Management LLC 42,002$207,0000.01%
JENNISON ASSOCIATES LLC 1,385,067$6,565,0000.01%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders